Alliance Pharma PLC received a notification of major holdings from Slater Investments, a shareholder, on 23rd July 2024. The reason for notification was an acquisition or disposal of voting rights. The threshold was crossed on 4th January 2024, and the total positions of Slater Investments show a 12% voting rights attached to shares, with a total of 64,825,000 voting rights held in the issuer.

The resulting situation on the date the threshold was crossed or reached indicates a 12% voting rights attached to shares. This is an increase from the previous notification, which showed 11.04% voting rights. The full chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held starts with Mark Slater as the ultimate controlling person, with Slater Investments holding 12% of voting rights.

The notification also includes details of financial instruments, but no information was provided in relation to proxy voting or additional information. The completion date for this notification was 5th January 2024, and it was supplied by Euroland.com.